[go: up one dir, main page]

GB202119034D0 - Polypeptide - Google Patents

Polypeptide

Info

Publication number
GB202119034D0
GB202119034D0 GBGB2119034.3A GB202119034A GB202119034D0 GB 202119034 D0 GB202119034 D0 GB 202119034D0 GB 202119034 A GB202119034 A GB 202119034A GB 202119034 D0 GB202119034 D0 GB 202119034D0
Authority
GB
United Kingdom
Prior art keywords
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2119034.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Freeline Therapeutics Ltd
Original Assignee
Freeline Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Freeline Therapeutics Ltd filed Critical Freeline Therapeutics Ltd
Priority to GBGB2119034.3A priority Critical patent/GB202119034D0/en
Publication of GB202119034D0 publication Critical patent/GB202119034D0/en
Priority to PCT/GB2022/052792 priority patent/WO2023079301A1/en
Priority to PCT/GB2022/052787 priority patent/WO2023079297A1/en
Priority to TW111142211A priority patent/TW202323270A/en
Ceased legal-status Critical Current

Links

GBGB2119034.3A 2021-11-04 2021-12-24 Polypeptide Ceased GB202119034D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB2119034.3A GB202119034D0 (en) 2021-12-24 2021-12-24 Polypeptide
PCT/GB2022/052792 WO2023079301A1 (en) 2021-11-04 2022-11-04 Assays using mutant complement factor i variants with decreased activity
PCT/GB2022/052787 WO2023079297A1 (en) 2021-11-04 2022-11-04 Mutant complement factor i variants with increased activity
TW111142211A TW202323270A (en) 2021-11-04 2022-11-04 Polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2119034.3A GB202119034D0 (en) 2021-12-24 2021-12-24 Polypeptide

Publications (1)

Publication Number Publication Date
GB202119034D0 true GB202119034D0 (en) 2022-02-09

Family

ID=80111794

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2119034.3A Ceased GB202119034D0 (en) 2021-11-04 2021-12-24 Polypeptide

Country Status (1)

Country Link
GB (1) GB202119034D0 (en)

Similar Documents

Publication Publication Date Title
IL289122A (en) Polypeptides
GB202017649D0 (en) Polypeptide
GB202007441D0 (en) Polypeptide
IL289119A (en) Polypeptides
IL288419A (en) Recombinant herpesvirales vector
IL299811A (en) Polypeptide
IL288412A (en) Peptides
IL312556A (en) Novel peptides
GB202007532D0 (en) Polypeptides
GB201810052D0 (en) Polypeptide
GB202019879D0 (en) Polypeptide
IL308465A (en) Sars-cov-2 polypeptides
GB202117405D0 (en) Peptide
IL290019A (en) Melanocyte-regulating peptides
GB202019908D0 (en) Cripr polypeptides
GB201918693D0 (en) Peptide
GB202119034D0 (en) Polypeptide
GB202105924D0 (en) Polypeptide
GB202103001D0 (en) Polypeptide
GB202100648D0 (en) Polypeptide
GB202013372D0 (en) Polypeptide
GB202011813D0 (en) Polypeptide
GB202005333D0 (en) Polypeptide
GB202319601D0 (en) Polypeptide
GB202102598D0 (en) An isolated polypeptide

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)